Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Debio 0932 |
Synonyms | |
Therapy Description |
Debio0932 (CUDC-305) is a second-generation Hsp90 inhibitor, which may decrease tumor cell proliferation and increase sensitivity to cytotoxic agents (Cancer Res August 1, 2015 75; 683, PMID: 25646368). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Debio 0932 | CUDC-305|Debio0932 | HSP90 Inhibitor 35 | Debio0932 (CUDC-305) is a second-generation Hsp90 inhibitor, which may decrease tumor cell proliferation and increase sensitivity to cytotoxic agents (Cancer Res August 1, 2015 75; 683, PMID: 25646368). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|